Literature DB >> 5940523

Studies on the control of hypertension. 8. Mortality, morbidity, and remissions during twelve years of intensive therapy.

H M Perry, H A Schroeder, F J Catanzaro, D Moore-Jones, G H Camel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5940523     DOI: 10.1161/01.cir.33.6.958

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

Review 1.  Risks versus benefits of withdrawing antihypertensive therapy.

Authors:  H P Schobel; R E Schmieder; F H Messerli
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 2.  When is discontinuation of antihypertensive therapy indicated?

Authors:  R E Schmieder; J K Rockstroh
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

3.  Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness.

Authors:  C de White; R B Royds; P Turner
Journal:  Postgrad Med J       Date:  1974-12       Impact factor: 2.401

4.  Treatment of malignant hypertension. The influence of etiology on the survival in 12 consecutive patients.

Authors:  Y E Cummings; M G Dillard
Journal:  J Natl Med Assoc       Date:  1974-03       Impact factor: 1.798

5.  Management of malignant hypertension complicated by renal insufficiency: further experience.

Authors:  J W Woods; W B Blythe
Journal:  Trans Am Clin Climatol Assoc       Date:  1968

6.  Developmental patterns in hypertensive cardiovascular disease: fact or fiction?

Authors:  C B Thomas
Journal:  Bull N Y Acad Med       Date:  1969-09

Review 7.  Malignant or accelerated hypertension.

Authors:  N D Vaziri
Journal:  West J Med       Date:  1984-04

8.  Malignant hypertension.

Authors:  E Z Rabin
Journal:  Can Med Assoc J       Date:  1978-04-22       Impact factor: 8.262

9.  Hypertension and strokes.

Authors:  J L Corbett
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 10.  Withdrawal of antihypertensive therapy in the elderly. The issues.

Authors:  M D Fotherby
Journal:  Drugs Aging       Date:  1995-06       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.